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Abstract
Purpose
To demonstrate feasibility of automated 3D volumetry of central pulmonary arteries based
on magnetic resonance angiography (MRA), to assess pulmonary artery volumes in
patients with pulmonary hypertension compared to healthy controls, and to investigate the
potential of the technique for predicting pulmonary hypertension.
Methods
MRA of pulmonary arteries was acquired at 1.5T in 20 patients with pulmonary arterial
hypertension and 21 healthy normotensive controls. 3D model-based image analysis soft-
ware was used for automated segmentation of main, right and left pulmonary arteries (MPA,
RPA and LPA). Volumes indexed to vessel length and mean, minimum and maximum diam-
eters along the entire vessel course were assessed and corrected for body surface area
(BSA). For comparison, diameters were also manually measured on axial reconstructions
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and double oblique multiplanar reformations. Analyses were performed by two cardiovascu-
lar radiologists, and by one radiologist again after 6 months.
Results
Mean volumes of MPA, RPA and LPA for patients/controls were 5508 ± 1236/3438 ± 749,
3522 ± 934/1664 ± 468 and 3093 ± 692/1812 ± 474 μl/(cm length x m2 BSA) (all p<0.001).
Mean, minimum and maximum diameters along the entire vessel course were also signifi-
cantly increased in patients compared to controls (all p<0.001). Intra- and interobserver
agreement were excellent for both volume and diameter measurements using 3D segmen-
tation (intraclass correlation coefficients 0.971–0.999, p<0.001). Area under the curve for
predicting pulmonary hypertension using volume was 0.998 (95% confidence interval
0.990–1.0, p<0.001), compared to 0.967 using manually measured MPA diameter (95%
confidence interval 0.910–1.0, p<0.001).
Conclusions
Automated MRA-based 3D volumetry of central pulmonary arteries is feasible and demon-
strated significantly increased volumes and diameters in patients with pulmonary arterial
hypertension compared to healthy controls. Pulmonary artery volume may serve as a supe-
rior predictor for pulmonary hypertension compared to manual measurements on axial
images but verification in a larger study population is warranted.
Introduction
Pulmonary hypertension (PH) is defined by an elevation of the mean pulmonary artery
pressure 25 mmHg at rest on invasive right heart catheterization [1]. The condition carries a
poor prognosis if it is not diagnosed and treated early [2,3]. However, prompt diagnosis
remains challenging for various reasons [4]. The unspecific clinical presentation with symp-
toms such as dyspnea or fatigue does not directly suggest the diagnosis of PH [1]. Additionally,
definite diagnosis requires right heart catheterization and thus an invasive procedure because
non-invasive techniques have not proven sufficient accuracy yet [5–8].
Among other non-invasive methods, measurement of pulmonary artery diameters on axial
computed tomography (CT) images has been suggested to assist diagnosis of PH [7,8].
Although pulmonary artery diameters measured on axial CT images are on average signifi-
cantly increased in patients with PH, their sensitivity and specificity for predicting PH are only
moderate [7–10]. An inherent limitation of measurements on axial CT images is that they are
only a two-dimensional representation of three-dimensional geometries. Therefore, measure-
ments derived from three-dimensional (3D) segmentation of pulmonary arteries might be
more accurate for predicting PH.
3D segmentation of pulmonary arteries has been investigated in two previous studies based
on CT data. The first study assessed the volume of intrapulmonary arteries, but not of the
extrapulmonary arteries [11]. Although this study showed good correlation between intrapul-
monary artery volume and pulmonary artery pressures, there was a significant overlap of intra-
pulmonary artery volumes in patients with and without PH thus hampering its usefulness for
predicting PH [11]. The second study demonstrated the potential of 3D segmentation of the
main, right and left pulmonary arteries by analyzing maximum diameters perpendicular to the
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respective vessel course, but did not investigate three-dimensional changes of pulmonary arter-
ies [12]. To our knowledge, 3D analysis of the geometries of the main, right and left pulmonary
arteries as well as 3D segmentation of pulmonary arteries based on magnetic resonance angiog-
raphy (MRA) have not yet been published.
Purpose of this study was to demonstrate feasibility of 3D segmentation of central pulmo-
nary arteries based on MRA, to assess 3D central pulmonary artery volumes in patients with
PH compared to healthy controls, and to investigate the potential of the technique for predict-
ing PH.
Materials and Methods
Subjects
The study was approved by the institutional review board of the University of Heidelberg and
written informed consent was obtained prior to enrolment into the study. 20 consecutive
patients (mean age 50 years, age range 19–72, 14 female, 6 male) with pulmonary arterial
hypertension (WHO classification Group 1) confirmed by right heart catheterization (mean
mPAP 53.7 ± 12.6 mmHg) undergoing MRA were prospectively included. Consecutive MRA
acquisitions of 21 healthy controls without history of cardiovascular disease and with normal
blood pressure (mean age 32 years, age range 21–51, 9 female, 12 male) served as reference.
Mean body surface area (BSA) calculated according to the Du Bois and Du Bois formula was
1.79 ± 0.20 for patients and 1.84 ± 0.18 for healthy controls (p = n.s.) [13].
Image Acquisition
A 1.5 T clinical MR scanner (Magnetom Avanto, Siemens, Erlangen, Germany) and a standard
phased array body coil were used for image acquisition. For contrast-enhanced MRA, a three-
dimensional T1-weigthed gradient echo spoiled FLASH sequence supplied by the manufac-
turer was applied in a coronal orientation (Fig 1). The following sequence parameters were
used: slice thickness, 1.6 mm; in-plane resolution, 1.04 x 1.04 mm; repetition/echo time (TR/
TE), 3.05/1.27 ms; flip angle 25°; parallel imaging factor 2; 120 slices per slab. Acquisition was
performed in an inspiratory breath-hold. Gadolinium contrast agent was administered with a
dose of 0.1 mmol/kg body weight via an ante-cubital vein at 2 ml/s followed by a saline flush of
20 ml at the same injection rate.
Image Analysis
All image analyses were based on the unsubtracted MRA data. For assessment of interobserver
agreement, all image analyses were performed by two cardiovascular radiologists. For assess-
ment of intraobserver agreement, one of the two radiologists conducted image analysis for a
second time after 6 months without reviewing the previous measurements. Each read was done
in a different random order and blinded to the diagnosis.
Automated three-dimensional segmentation was performed using three-dimensional
model-based image analysis software that was previously validated [14–16]. All information
surrounding the software including the segmentation algorithm has been previously pub-
lished [14–16]. In short, the software uses a three-dimensional analytic intensity model
representing both shape and image intensities of vessels. This model is fitted to the image
intensities within a volume of interest resulting in a three-dimensional model of the vessels of
interest. The accuracy of the segmentation is improved by an automatic two-step refinement
procedure.
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For this study, one seed point was placed in the center of the main, right and left pulmonary
arteries, respectively (MPA, RPA and LPA). Starting at the seed point, the software automatically
performed segmentation of the respective vessel both proximal and distal to the seed point and
calculated centerlines along the geometric centroid of each segmented vessel (Fig 2).
The reader then visually verified the segmentation result and determined the level of the
pulmonary valve, the MPA bifurcation and the take-off point of the upper lobe artery for both
RPA and LPA. Pulmonary artery volumes were then computed by the software using the fol-
lowing standardized approach. MPA volume was defined as the volume between a level 5 mm
distal to the level of the pulmonary valve and a level 5 mm proximal to the MPA bifurcation.
RPA and LPA volumes were defined as the volumes between the start of the RPA/LPA at the
MPA bifurcation and the take-off point of the right/left upper lobe artery, respectively. The
respective vessel length was computed along the vessel centerline.
In addition to that, average vessel diameter perpendicular to the vessel centerline was auto-
matically computed for every 1 mm along the centerline (Fig 2). Mean, minimum and maxi-
mum of the average diameter along the entire course of the respective artery were then also
provided by the software. Three-dimensional segmentation and analysis took approximately
10 min per patient.
For comparison purposes, the MPA, RPA and LPA diameters were manually measured on
axial reconstructions at standardized locations. MPA diameter was measured at the level of the
RPA as done in the Framingham Heart Study (Fig 3) [17]. RPA and LPA diameter were mea-
sured 1.5 cm distally to the MPA bifurcation. Axial reconstructions were obtained from the
Fig 1. Example of image acquisition.Representative example of inspiratory breath-hold magnetic
resonance angiography acquired in coronal orientation used for automated 3D segmentation of central
pulmonary arteries.
doi:10.1371/journal.pone.0162516.g001
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same MRA data sets used for 3D segmentation. These measurements were performed in a
randomized order that was different to the randomized order for 3D segmentation by the
respective reader again blinded to the diagnosis and also blinded to the results of the 3D
segmentation.
Fig 3. Example of manual measurement. Example of manual measurement of MPA diameter performed
on axial reconstructions of the same magnetic resonance angiography data used for 3D segmentation.
Manual measurements were performed for comparison with automated measurements.
doi:10.1371/journal.pone.0162516.g003
Fig 2. Example of 3D segmentation result.Representative automated 3D segmentation of central pulmonary arteries
based on magnetic resonance angiography used for automated measurements. A color-coding is used to visualize
pulmonary artery diameters of the 3D segmentation along the vessel course.
doi:10.1371/journal.pone.0162516.g002
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Finally, the maximumMPA, RPA and LPA diameters were manually measured by the first
reader using double oblique multiplanar reformations (MPR) using the same MRA data sets at
the same standardized locations. Again, measurements were performed blinded to the diagno-
sis and also blinded to all other results and in a randomized order that was different to the ran-
domized orders for 3D segmentation and axial reconstructions.
Statistical Analysis
All volumes were indexed to the respective vessel length and corrected for BSA. All diameters
were corrected for BSA. Shapiro-Wilk test was performed showing normal distribution of the
analyzed data. Data is shown as mean ± standard deviation. The two-sided t-test for indepen-
dent samples was applied to test for differences between PH patients and healthy controls.
Inter- and intraobserver agreements were calculated as Shrout and Fleiss intraclass correlation
coefficients. Overall agreement between measurements was assessed using Bland-Altman plots.
The limits of agreement were calculated as mean ± 1.96 x standard deviation.
Area under the curve (AUC) using receiver-operating characteristic (ROC) analysis of aver-
age volume of RPA and LPA (VOLAVG) as well as their total volume (VOLTOT) was calculated
to predict PH. For comparison, AUC was calculated for MPA diameter, average of RPA and
LPA diameters (RPA/LPA diameter) and greatest pulmonary artery diameter measured on
axial reconstructions and double oblique MPR.
A p-value of 0.05 was considered to represent statistical significance. All analyses were
performed with SPSS Version 23.0 (SPSS Inc., Chicago, IL, USA).
Results
Automated 3D segmentation was successful and deemed accurate in all cases apart from the
MPA in one patient and the RPA in two healthy controls. In these cases, lower contrast in the
pulmonary arteries compared to the ascending aorta secondary to suboptimal bolus timing was
observed resulting in partial inclusion of the ascending aorta into the segmentation result. The
affected segments were excluded from further analysis.
Pulmonary artery volumes and diameters based on 3D segmentation were significantly
increased in patients with PH compared to healthy subjects (Tables 1 and 2). Diameters manu-
ally measured on axial reconstructions and on double oblique MPR were also significantly
increased in patients compared to healthy controls (Table 2). Measurements by 3D segmenta-
tion could be reproduced with excellent intra- and interobserver agreement (Tables 1 and 2).
Bland-Altman plots did not show any systematic differences for repeated measurements (Fig
4). In comparison, intra- and interobserver agreement of manual axial MPA, RPA and LPA
diameter measurements were slightly lower (Table 2), also visible in Bland-Altman plots
(Fig 4).
Table 1. Pulmonary artery volumes indexed to vessel length and corrected for BSA [μl/(cm length x m2 BSA)].
Pulmonary artery Patients Healthy controls P-Value Intraobserver agreement Interobserver agreement
Main 5508 ± 1236 3438 ± 749 <0.001 0.999* 0.998*
Right 3522 ± 934 1664 ± 468 <0.001 0.998* 0.998*
Left 3093 ± 692 1812 ± 474 <0.001 0.995* 0.995*
Data are means ± standard deviation calculated from means of measurements from all reads.
*P-values of intra- and interobserver agreement were all p<0.001.
doi:10.1371/journal.pone.0162516.t001
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Fig 4. Bland-Altman plots for intra- and interobserver agreement. Bland-Altman plots show the differences between the two
measurements performed by reader 1 (upper row) and the differences between measurements by the two readers (lower row) for automated
3D volume measurements (left), automated 3D mean diameter measurements (center) and manual diameter measurements (right) plotted
against the means of the respective measurements. The straight line represents the mean difference, the dotted lines the limits of
agreement. No systematic differences for repeated measurements could be observed. There is better agreement of automated 3D mean
diameter measurements compared to manual diameter measurements.
doi:10.1371/journal.pone.0162516.g004
Table 2. Pulmonary artery diameters corrected for BSA [mm/m2 BSA].
Pulmonary artery Diameter Patients Healthy controls P-Value Intraobserver agreement Interobserver agreement
Main Mean3D 19.7 ± 2.2 15.4 ± 1.3 <0.001 0.998* 0.997*
Min3D 18.1 ± 2.0 14.8 ± 1.2 <0.001 0.984* 0.977*
Max3D 21.1 ± 2.6 16.4 ± 1.5 <0.001 0.993* 0.988*
Manualaxial 19.7 ± 2.6 14.4 ± 1.5 <0.001 0.962* 0.959*
ManualMPR 20.1 ± 2.6 15.0 ± 1.5 <0.001 - -
Right Mean3D 15.7 ± 2.0 10.6 ± 1.6 <0.001 0.998* 0.998*
Min3D 15.0 ± 1.9 10.0 ± 1.4 <0.001 0.997* 0.996*
Max3D 16.9 ± 2.4 12.0 ± 2.0 <0.001 0.989* 0.994*
Manualaxial 15.6 ± 2.0 10.2 ± 1.5 <0.001 0.938* 0.965*
ManualMPR 16.1 ±2.0 10.6 ± 1.5 <0.001 - -
Left Mean3D 14.8 ± 1.5 11.1 ± 1.5 <0.001 0.994* 0.994*
Min3D 14.1 ± 1.6 10.0 ± 1.3 <0.001 0.986* 0.986*
Max3D 15.6 ± 1.7 12.5 ± 1.7 <0.001 0.971* 0.987*
Manualaxial 15.0 ± 1.5 10.9 ± 1.6 <0.001 0.965* 0.965*
ManualMPR 15.7 ± 1.6 11.3 ± 1.7 <0.001 - -
Data are means ± standard deviation calculated from means of measurements from all reads. 3D indicates measurements by automated 3D segmentation,
axial indicates manual measurements on axial reconstructions and MPR indicates manual measurements by double oblique MPR.
*P-values of intra- and interobserver agreement were all p<0.001.
doi:10.1371/journal.pone.0162516.t002
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AUC for predicting PH by VOLAVG corrected for BSA was 0.998 (95% confidence interval
0.990–1.0, p<0.001) and by VOLTOT corrected for BSA 0.997 (95% confidence interval
0.989–1.0, p<0.001). Sensitivity, specificity, positive predictive value and negative predictive
value of VOLAVG corrected for BSA were 100%, 95%, 95% and 100% using 2,500 μl/(cm
length x m2 BSA) as sex-independent cut-off. For comparison, AUC for predicting PH by
diameters manually measured on axial reconstructions was 0.967 for MPA diameter corrected
for BSA (95% confidence interval 0.910–1.0, p<0.001), 0.990 for RPA/LPA diameter cor-
rected for BSA (95% confidence interval 0.971–1.0, p<0.001) and 0.971 for greatest pulmo-
nary artery diameter corrected for BSA (95% confidence interval 0.922–1.0, p<0.001).
Sensitivity, specificity, positive predictive value and negative predictive value of RPA/LPA
diameter corrected for BSA were 100%, 86%, 86% and 100% using 12.5 mm/m2 BSA as sex-
independent cut-off. AUC for predicting PH by diameters manually measured on double
oblique MPR was 0.953 for MPA diameter corrected for BSA (95% confidence interval 0.886–
1.0, p<0.001), 0.986 for RPA/LPA diameter corrected for BSA (95% confidence interval
0.959–1.0, p<0.001).
Discussion
MRA-based automated 3D segmentation of central pulmonary arteries is feasible and demon-
strated significantly increased volumes and diameters of main, right and left pulmonary arteries
in patients with pulmonary arterial hypertension compared to healthy controls. Measurements
by 3D segmentation could be reproduced with excellent intra- and interobserver agreement.
Furthermore, pulmonary artery volume showed higher sensitivity and specificity for predicting
PH compared to pulmonary artery diameters manually measured on axial reconstructions.
These findings are well in accordance with previous studies investigating pulmonary artery
diameters. Patients with PH have been shown to exhibit significantly increased central pulmo-
nary artery diameters [18,19]. Besides, diameter measurements in healthy controls in our study
are in the normal range established by previous studies [17].
Previous studies also demonstrated an only moderate predictive value of MPA diameter
manually measured on axial images [7–10]. In our study, the predictive value of RPA/LPA
diameter manually measured on axial reconstructions or double oblique MPR was higher com-
pared to that of manual MPA diameters as well as greatest pulmonary artery diameter, but
highest predictive value was achieved for pulmonary artery volume assessed by automated 3D
volumetry. This may be explained by better depiction of the three-dimensional nature of geo-
metric changes that pulmonary arteries undergo as a consequence of increased intraarterial
pressures. Furthermore, quantifying geometric changes along the entire vessel course may be
less prone to errors than measuring pulmonary artery diameters only at a single location. It has
to be noted that measurements on axial imaging planes can be performed more easily in the
clinical setting. Besides, inter- and intraobserver agreement and predictive value of axial mea-
surements in this study might be considered sufficient for clinical routine. However, the addi-
tional effort of 3D volumetry may be justified by the improved predictive value. And although
sensitivity and specificity for predicting PH will probably be lower both for manual axial mea-
surements and automated 3D volumetry in a larger study population, it is likely that automated
3D volumetry will still be superior to manual measurements.
To our knowledge, this is the first study demonstrating the feasibility of MRA-based 3D
segmentation of pulmonary arteries. Similar to CT, acquisition of MRA data can be per-
formed noninvasively and in one breath-hold, but with the additional advantage of not
requiring ionizing radiation. This might be particularly useful when performing repeated
acquisitions for therapy monitoring. Further studies are needed to assess the value of the
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presented technique for therapy monitoring as well as predicting treatment response and
overall survival, respectively.
It might be criticized that the healthy subject group included more males and had a lower
mean age compared to the patient group. However, both males and younger subjects tend to
have larger pulmonary arteries thus potentially reducing rather than increasing the differences
between the PH patient and the healthy subject groups in the present study (4). Another limita-
tion may be the relatively small number of subjects. However, the primary purpose of the pres-
ent study was to demonstrate the feasibility and the potential of automated MRA-based 3D
volumetry justifying a subsequent study in a larger patient population. Besides, inter-exam
reproducibility was not investigated because we wanted to avoid repeated contrast medium
administration within a short interval.
Conclusions
Automated MRA-based 3D volumetry of central pulmonary arteries is feasible and demon-
strated significantly increased volumes and diameters in patients with pulmonary arterial
hypertension compared to healthy controls. Pulmonary artery volume may serve as a superior
predictor for pulmonary hypertension compared to manual measurements on axial images but
verification in a larger study population is warranted.
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